| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 00:06 | Seaport reiterates NVR stock Sell rating with $5,664 target | ||
| Mo | Organogenesis plans rolling BLA submission for ReNu by year-end | ||
| Mo | Freedom Broker initiates Inogen stock coverage with buy rating on respiratory platform growth | ||
| Mo | Betterware de México names Raúl del Villar as CFO | ||
| Mo | Mawson Infrastructure appoints five new directors under cooperation deal | ||
| Mo | XMax establishes AI subsidiary following board approval | ||
| Mo | Integer board chair Bailey to step down, Spence to succeed | ||
| Mo | Mach Natural Resources unitholders to sell 9M common units | ||
| Mo | Romande Energie 2025 slides: 60% EBITDA jump fuels Vision 2040 | ||
| Mo | Mizuho cuts Robinhood stock price target on softer revenue outlook | ||
| Mo | Raymond James reiterates Market Perform on Robinhood stock amid trading volume concerns | ||
| Mo | Jefferies upgrades MercadoLibre stock rating on growth investments | ||
| Mo | Franklin Templeton reports $1.68 trillion AUM with $5B inflows | ||
| Mo | Brink's expands credit facility to $3.85 billion for Atleos deal | ||
| Mo | CareTrust REIT closes $119M in healthcare property deals | ||
| Mo | Exponent names new president and CFO, board chairman | ||
| Mo | IQSTEL reports 11.9% revenue growth for fiscal 2025 | ||
| Mo | Cognex completes sale of Japan trading unit for $11.9 million | ||
| Mo | FMC receives EU approval for Isoflex herbicide active ingredient | ||
| Mo | Neuronetics CFO Steven Pfanstiel to depart in May | ||
| Mo | Clear Street raises Protagonist Therapeutics price target on drug potential | ||
| Mo | Jefferies raises Cheniere Energy stock price target to $330 on EBITDA beat | ||
| Mo | Oppenheimer cuts Soleno Therapeutics stock rating on acquisition | ||
| Mo | Jefferies downgrades Las Vegas Sands on margin pressure due to strategy shift | ||
| Mo | Twilio Rises As Jefferies Upgrades To 'Buy', Sees $1.15B in its voice revenue by 2 |